Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidemic Meningitis”

128 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 128 results

Not applicableUnknownNCT04594785
What this trial is testing

Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection

Who this might be right for
Streptococcus PneumoniaStreptococcus Pyogenes InfectionNeisseria Meningitides Meningitis
University Hospital, Montpellier 150
Large-scale testing (Phase 3)Study completedNCT00657709
What this trial is testing

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Who this might be right for
Serogroup B Meningococcal Meningitis
Novartis Vaccines 3,630
Testing effectiveness (Phase 2)Study completedNCT01434680
What this trial is testing

Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis 992
Post-approval studies (Phase 4)Study completedNCT00310687
What this trial is testing

Persistence of Immune Response After Vaccination With MCC

Who this might be right for
Prevention of Meningococcal Infection
Novartis 1,244
Large-scale testing (Phase 3)Study completedNCT03621670
What this trial is testing

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,196
Testing effectiveness (Phase 2)Study completedNCT00310856
What this trial is testing

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 175
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Large-scale testing (Phase 3)Study completedNCT00310674
What this trial is testing

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Who this might be right for
Prevention of Meningococcal Infection
Novartis 150
Post-approval studies (Phase 4)UnknownNCT03682939
What this trial is testing

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population

Who this might be right for
HivMeningitis, MeningococcalHIV Infections
St George's, University of London 55
Not applicableStudy completedNCT04061382
What this trial is testing

Sero-epidemiological Survey of England in 2019/2020 - COVID-19

Who this might be right for
Serogroup C Meningococcal MeningitisDiphtheriaCOVID-19
University of Oxford 2,963
Post-approval studies (Phase 4)Study completedNCT02724046
What this trial is testing

Ciprofloxacin for the Prevention of Meningococcal Meningitis

Who this might be right for
Meningitis, Meningococcal
Epicentre 300
Early research (Phase 1)Study completedNCT00248833
What this trial is testing

Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
U.S. Army Medical Research and Development Command 34
Early research (Phase 1)Study completedNCT04236960
What this trial is testing

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Who this might be right for
Meningococcal Infections
Walvax Biotechnology Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT02842853
What this trial is testing

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 3,344
Post-approval studies (Phase 4)Study completedNCT01424644
What this trial is testing

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Who this might be right for
Meningococcal Meningitis
Novartis 801
Post-approval studies (Phase 4)Study completedNCT00310700
What this trial is testing

Kinetics of B Cell Response in Infants Menjugate Vaccination

Who this might be right for
Prevention of Meningococcal Infection
Novartis 75
Early research (Phase 1)UnknownNCT02878291
What this trial is testing

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 200
Early research (Phase 1)Study completedNCT01482052
What this trial is testing

Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 60
Large-scale testing (Phase 3)Study completedNCT00483574
What this trial is testing

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,378
Testing effectiveness (Phase 2)Study completedNCT02199691
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,715
Load More Results